Study finds that HIV populations in people with higher viral loads also have higher rates of viral recombination

Researchers investigated whether denser intrahost HIV populations had a higher incidence of coinfection and recombination.

Comprehensive cost and utilization of commercial CAR-T therapy in pediatric B-ALL patients

A new editorial paper was published in Oncoscience (Volume 11) on April 25, 2024, entitled, “The price of hope: CAR-T therapy in pediatric leukemia.”

May 17, 2024

Buoyed by billion-dollar deals, its stock is up 50% this year. How did Boston Scientific get its mojo back?

The day after completing its latest billion-dollar deal, Boston Scientific dispatched food trucks to hand out fried chicken sandwiches and burritos to Silk Road Medical

November 13, 2024

Century Therapeutics nabs Bristol Myers alum as CEO; Enhertu star Daiichi Sankyo makes changes in Europe

→ Century Therapeutics announced the departure of CEO Lalo Flores in April, and the Philadelphia cell therapy biotech has found his successor. Brent Pfeiffenberger just

November 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.